Browsing: Clinical > Infection control
International collaborative research has analyzed Ebola virus genomes from the 2013–2016 outbreak, uncovering the role of factors such as language and distance between cities.
Oral delivery of vaccines is an attractive approach but is hampered by a number of challenges. Here, the authors discuss the need to include immunostimulatory adjuvants in oral vaccines to overcome oral tolerance and elicit effector immune responses locally within the intestine.
Environmental change, and a growing and more connected population will promote vector-borne disease risk further. In this opinion piece, the authors discuss the role of climate modeling in disease prediction and epidemiology.
Researchers have identified the southern states of the USA as most at risk of high burden from Zika virus.
How can we ensure products remain pathogen free? In this editorial, the authors discuss the most common causes of food-borne illnesses, methods by which contamination is traditionally detected and what current research has to offer, specifically in the field of nanoscience.
In this piece, author Jean-François Etard, summarizes his work on the Postebogui cohort and argues that patients declared free of Ebola virus disease should receive follow-up for at least 18 months after discharge from treatment centers.
This review delves into new diagnostic Aspergillus spp. procedures, in addition, the authors look at intrinsic antifungal resistance and mechanisms of secondary resistance to triazoles in A. fumigatus.
Researchers have suggested that disease “superspreaders” may have been responsible for two-thirds of cases in the West Africa Ebola epidemic. Targeting these individuals could lead to better disease control measures in future outbreaks.
A study including over 10,000 patients has demonstrated a lower risk of all-cause 30-day mortality when Clostridium difficile infections are treated with vancomycin as opposed to metronidazole.